DrugPatentWatch Database Preview

Litigation for LINAGLIPTIN; METFORMIN HYDROCHLORIDE

« Back to Dashboard

US Court Litigation for LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,340,475	Purdue Pharma L.P. v. Sandoz Inc.		2012-06-28	2014-01-08	35:271 Patent Infringement	District Court, S.D. New York	None
6,340,475			2012-07-20	2013-09-24	35:271 Patent Infringement	District Court, S.D. New York	None
6,340,475	Purdue Pharma LP v. Sandoz Inc.		2012-10-10	2014-01-08	35:271 Patent Infringement	District Court, S.D. New York	None
6,340,475	Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.		2012-11-05	2016-06-29	35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None
6,340,475	Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.		2012-11-05		35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None

Patent Trial and Appeal Board Cases for LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,340,475	Purdue Pharma L.P.		2014-01-24	2014-01-24	Depomed, Inc.	Inter partes review		2014-07-10	JOHN SHELL
6,340,475	Purdue Pharma L.P.		2014-01-24	2014-01-24	Depomed, Inc.	Inter partes review		2014-07-10	JOHN SHELL
6,340,475	Endo Pharmaceutical Inc.		2014-04-17	2014-04-17	Depomed, Inc.	Inter partes review		2014-09-29	JOHN SHELL
6,340,475	Endo Pharmaceutical Inc.		2014-04-17	2014-04-17	Depomed, Inc.	Inter partes review		2014-09-29	JOHN SHELL
6,635,280	Purdue Pharma L.P.		2014-01-24	2014-01-24	DepoMed, Inc.	Inter partes review		2014-07-10	John Shell